||Recombinant Human CSF2 (Accession # CAA26822) Ala18-Glu144 was produced in E. coli-derived.
|Predicted N Terminal:
||Lyophilized from a 0.2 µm filtered solution in PBS.
||Measured in a cell proliferation assay using TF‑1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323.The ED50 for this effect is typically 6 - 30 pg/mL.
||Recombinant Human CSF2 has a calculated MW of 14 kDa.
||>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).